BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 34998839)

  • 1. Molecular pathways and role of epigenetics in the idiopathic pulmonary fibrosis.
    Velagacherla V; Mehta CH; Nayak Y; Nayak UY
    Life Sci; 2022 Feb; 291():120283. PubMed ID: 34998839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-transcriptome-based candidate therapeutic discovery for idiopathic pulmonary fibrosis.
    Wang Y; Yella JK; Ghandikota S; Cherukuri TC; Ediga HH; Madala SK; Jegga AG
    Ther Adv Respir Dis; 2020; 14():1753466620971143. PubMed ID: 33167785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research Advances on DNA Methylation in Idiopathic Pulmonary Fibrosis.
    Luo QK; Zhang H; Li L
    Adv Exp Med Biol; 2020; 1255():73-81. PubMed ID: 32949391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenomics of idiopathic pulmonary fibrosis.
    Yang IV
    Epigenomics; 2012 Apr; 4(2):195-203. PubMed ID: 22449190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetics in lung fibrosis: from pathobiology to treatment perspective.
    Helling BA; Yang IV
    Curr Opin Pulm Med; 2015 Sep; 21(5):454-62. PubMed ID: 26176965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic Pulmonary Fibrosis: Where do We Stand and How Far to Go?
    Singh V; Ulasov I; Gupta S; Singh A; Roy VK; Kharwar RK
    Discov Med; 2024 Jan; 36(180):22-47. PubMed ID: 38273744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of TGF-β Signaling in Lung Cancer Associated with Idiopathic Pulmonary Fibrosis.
    Saito A; Horie M; Micke P; Nagase T
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30445777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetics of idiopathic pulmonary fibrosis.
    Yang IV; Schwartz DA
    Transl Res; 2015 Jan; 165(1):48-60. PubMed ID: 24746870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation of miR-17~92 contributes to the pathogenesis of pulmonary fibrosis.
    Dakhlallah D; Batte K; Wang Y; Cantemir-Stone CZ; Yan P; Nuovo G; Mikhail A; Hitchcock CL; Wright VP; Nana-Sinkam SP; Piper MG; Marsh CB
    Am J Respir Crit Care Med; 2013 Feb; 187(4):397-405. PubMed ID: 23306545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase-2 in idiopathic pulmonary fibrosis.
    Coward WR; Feghali-Bostwick CA; Jenkins G; Knox AJ; Pang L
    FASEB J; 2014 Jul; 28(7):3183-96. PubMed ID: 24652950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis.
    Ma H; Wu X; Li Y; Xia Y
    Front Pharmacol; 2022; 13():963054. PubMed ID: 35935869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets.
    Ballester B; Milara J; Cortijo J
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30704051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered epigenetic features in circulating nucleosomes in idiopathic pulmonary fibrosis.
    Guiot J; Struman I; Chavez V; Henket M; Herzog M; Scoubeau K; Hardat N; Bondue B; Corhay JL; Moermans C; Louis R
    Clin Epigenetics; 2017; 9():84. PubMed ID: 28824731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of DNA methylation and gene expression in idiopathic pulmonary fibrosis.
    Yang IV; Pedersen BS; Rabinovich E; Hennessy CE; Davidson EJ; Murphy E; Guardela BJ; Tedrow JR; Zhang Y; Singh MK; Correll M; Schwarz MI; Geraci M; Sciurba FC; Quackenbush J; Spira A; Kaminski N; Schwartz DA
    Am J Respir Crit Care Med; 2014 Dec; 190(11):1263-72. PubMed ID: 25333685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide DNA methylation analysis of Astragalus and Danshen on the intervention of myofibroblast activation in idiopathic pulmonary fibrosis.
    Liu Q; Liu X; Wang G; Wu F; Hou Y; Liu H
    BMC Pulm Med; 2023 Sep; 23(1):325. PubMed ID: 37667288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Mechanisms and Cellular Contribution from Lung Fibrosis to Lung Cancer Development.
    Samarelli AV; Masciale V; Aramini B; Coló GP; Tonelli R; Marchioni A; Bruzzi G; Gozzi F; Andrisani D; Castaniere I; Manicardi L; Moretti A; Tabbì L; Guaitoli G; Cerri S; Dominici M; Clini E
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global methylation patterns in idiopathic pulmonary fibrosis.
    Rabinovich EI; Kapetanaki MG; Steinfeld I; Gibson KF; Pandit KV; Yu G; Yakhini Z; Kaminski N
    PLoS One; 2012; 7(4):e33770. PubMed ID: 22506007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic targets in idiopathic pulmonary fibrosis.
    Kolb M; Bonella F; Wollin L
    Respir Med; 2017 Oct; 131():49-57. PubMed ID: 28947042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation in pulmonary fibrosis and lung cancer.
    Duan J; Zhong B; Fan Z; Zhang H; Xu M; Zhang X; Sanders YY
    Expert Rev Respir Med; 2022 May; 16(5):519-528. PubMed ID: 35673969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetics in idiopathic pulmonary fibrosis.
    Tzouvelekis A; Kaminski N
    Biochem Cell Biol; 2015 Apr; 93(2):159-70. PubMed ID: 25659821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.